A new antihypertensive association: Preterax®, low doses of ACE inhibitor and thiazide in the same pill;Le médicament du mois: Preterax® la première association fixe faiblement dosée contenant un inhibiteur d'enzyme de conversion et un diurétique thiazide

Revue Medicale de Liege

Volumn 59, Issue 10, 2004, Pages 601-606

  Krzesinski, J M ^a  

^a CHU SART TILMAN   (Belgium)

Author keywords

Angiotensin converting enzyme inhibitor; Arterial hypertension; Diuretic; Drug therapy; Guidelines

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BIPRETERAX; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLICLAZIDE; INDAPAMIDE; INDAPAMIDE PLUS PERINDOPRIL; PERINDOPRIL; PLACEBO; PRETERAX; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG;

BLOOD PRESSURE REGULATION; CLINICAL PROTOCOL; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; DRUG UTILIZATION; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; LOW DRUG DOSE; MONOTHERAPY; OUTCOMES RESEARCH; PILL; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; SYSTOLIC BLOOD PRESSURE; ARTICLE; DRUG COMBINATION; REMISSION; TIME;

DRUG COMBINATIONS; HUMANS; HYPERTENSION; INDAPAMIDE; PERINDOPRIL; REMISSION INDUCTION; TIME FACTORS;

EID: 9644303102     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Traitement initial de l'hypertension: état de la question.- Folia Pharmacotherapeutica, 2004, 41, n04, 28-32.
2. Krzesinski JM.- Nouvelles directives américaines et européennes en 2003 pour la prise en charge de l'hypertension artérielle. Rev Med Liège, 2003, 58, 563-571.
3. Blood pressure lowering treatment trialists'Collaboration.- Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet, 2003, 362, 1527-1535.
4. Guidelines Committee.- 2003 European Society of hypertension-European Society of cardiology Guidelines for the management of Arterial Hypertension. J Hypertens, 2003, 21, 1011-1053.
5. Krzesinski JM.- Qualité de la prise en charge de l'hypertension artérielle. Pouvons-nous, devons-nous faire mieux? Rev Med Liège, 2002, 57, 202-206.
6. Andréjak M, Laville M, Duru G, et al.- Better efficacy in hypertension management with perindopril/indapamide (PER/IND) strategy compared to sequential or step by step strategies. STRATHE Study: STRAtegies of Treatment in Hypertension: Evaluation. J Hypertens, 2004, 22 (suppl 2), S384.
7. Krzesinski JM, Rorive M.- Y a-t-il une place d'emblée pour une bithérapie faiblement dosée dans le traitement de l'hypertension artérielle essentielle? Méd et Hyg, 2003, 61, 1556-1559.
8. Laurent S.- Very-low-dose combination of perindopril and indapamide: efficacy on blood pressure and target-organ damage. J Hypertens, 2003, 21 (suppl 3), S11-S18.
9. Chalmers J, Castaigne A, Morgan T, et al.- Efficacité au long cours d'une nouvelle association fixe très faiblement dosée IEC/diurétique en traitement de 1 ère intention chez l'hypertendu âgé. J Hypertens, 2000, 18, 327-337.
10. Chanudet X, De Champvallins M.- Antihypertensive efficacy and tolerability of low-dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension. Int J Clin Pract, 2001, 55 (4), 233-239.
11. Mallion JM, Chamontin B, Asmar R, et al.- Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON Study. Am J Hypertens, 2004, 17, 245-251.
12. Asmar R, London G, O'Rourke M, et al.- Improvement in blood pressure, arterial siffness and wave reflections with a very-low-dose perindopril/ indapamide combination in hypertension patient. A comparison with atenolol. Hypertension, 2001, 38, 922-926.
13. Dalhöf B. Gosse P, Guéret P. et al.- The P.I.C.X.E.L. Study: benefits of PRETERAX® on LVH reduction. J Hypertens, 2004, 22 (suppl 2), S410.
14. Mogensen CE, Viberti G, Halimi S, et al.- Effect of low-dose perindopril/indapamide on albumunuria in diabetes. PREterax® in albuMInuria rEgRession: PREMIER. Hypertension, 2003, 41, 1063-1071.
15. Chalmers J, MacMahon S.- ADVANCE: Action in diabetes and vascular disease-Preterax® and Diamicron® controlled evaluation. Diabetologica, 2001, 44, 1118-1120